BNB Plus Corp Secures European Patent to Accelerate Global mRNA Production

Munich, Wednesday, 18 March 2026.
Securing critical intellectual property rights through 2040, BNB Plus Corp’s new European patent empowers its advanced platform to deliver faster, cleaner mRNA production for the expanding biotherapeutics market.